Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer

Mise à jour : Il y a 4 ans
Référence : NCT01041027

Femme Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This phase II trial studies how well radiation therapy, paclitaxel, and carboplatin work in treating patients with high-risk endometrial cancer. Radiation therapy uses high energy x rays to kill tumor cells. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing or by stopping them from spreading. Giving radiation therapy with chemotherapy may kill more tumor cells.


Critère d'inclusion

  • Endometrial Adenocarcinoma,Stage IA Uterine Corpus Cancer,Stage IB Uterine Corpus Cancer,Stage II Uterine Corpus Cancer,Stage IIIA Uterine Corpus Cancer,Stage IIIB Uterine Corpus Cancer,Stage IIIC Uterine Corpus Cancer,Stage IVA Uterine Corpus Cancer,Stage IVB Uterine Corpus Cancer

Liens